Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD137 inhibitors(Tumor necrosis factor receptor superfamily member 9 inhibitors), IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors), OX40 inhibitors(Tumor necrosis factor receptor superfamily member 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Esophagitis | Discovery | - | 21 Jul 2023 | |
| Neoplasms | Discovery | - | 21 Jul 2023 |





